Canopus Biopharma In (CBIA) 0.1200 $CBIA Ebola Viral

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Canopus Biopharma In (CBIA) 0.1200 $CBIA

Ebola Viral Infections Pipeline Review, H2 2015 - Analysis, Technologies & Forecasts
M2 - Thu Dec 17, 3:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/zhmmv6/ebola_viral) has announced the addition of the "Ebola Viral Infections - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Ebola Viral Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Key Topics Covered: - The report provides a snapshot of the global therapeutic landscape of Ebola Viral Infections - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Ebola Viral Infections and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Ebola Viral Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages Benefits of this Report: - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Ebola Viral Infections - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Ebola Viral Infections pipeline depth and focus of Indication therapeutics Companies Mentioned Include: - Abivax S.A. - AmVac AG - AnGes MG, Inc. - Arno Therapeutics, Inc. - Canopus BioPharma Incorporated - Etubics Corporation - FIT Biotech Oy - Merck & Co., Inc. - Microbiotix, Inc. - Micropharm Limited - Toyama Chemical Co., Ltd. - United Therapeutics Corporation - Vaxeal Holding SA - XBiotech USA, Inc. For more information visit http://www.researchandmarkets.com/research/zh...bola_viral
UTHR: 102.11 (-3.17), MRK: 55.88 (-1.80)

Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study
PR Newswire Europe - Fri Dec 19, 8:00AM CST
Canopus BioPharma Inc. today announces that it has completed crucial research in confirming efficacy of a prescription drug: CB008 for Ebola Virus inhibition.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clean Energy Ventures Taps Ramsamy as Managing Partner

Updated Category News Views 0

Welcome to the New Guard at CEV There's a new sheriff in town at Clean Energy Ventures (CEV), and her name is Aruna Ramsamy. On a brisk day in Boston, the venture capital firm made waves by announcing Ramsamy as their new Managing Partner, a move designed to light up their European operations and ramp up investments in climate technologies. They're not just talking the...

Continue Reading
Valmet Grabs Tieto Unit, Aims for Autonomous Leap

Updated Category News Views 17

Valmet Makes a Strategic Move Alright, here's a bold move from Valmet: they've decided to snatch up Tieto’s manufacturing execution system (MES) business. Seems they're gunning for a quick leapfrog into the era of autonomous operations. Now, folks who dabble in the industry know this is akin to adding rocket fuel to their current setup. Valmet seriously aims to...

Continue Reading
Infosys Faces EPS Miss, Legal Scrutiny for Investors

Updated Category News Views 42

Infosys' Earnings Struggle When even a penny's worth of expectations falls short, the market isn't going to simply shrug it off. This was the case for Infosys Limited (NYSE: INFY) after they managed to miss analysts' earnings projections by a mere cent. On October 23, 2026, they revealed a second-quarter earnings report showing $0.20 per share, which was a penny below...

Continue Reading
HIMS Lawsuit: Investors Under the Gun Before Deadline

Updated Category News Views 71

HIMS Investors Find Themselves in Hot Water Well, it looks like the ball's in your court, folks. Hims & Hers Health, Inc. (NYSE: HIMS) has been caught in a whirlwind of legal drama, and if you're holding any $HIMS stock, you've got some decisions to make—and fast. With a looming November 2 deadline to step up in a securities class action, this is one of those...

Continue Reading
Rethinking Your Social Security Timing Strategy

Updated Category News Views 147

Janie Kelly Challenges Conventional Wisdom Janie Kelly, the brain behind Kelly Capital Partners, just dropped a truth bomb on when to start claiming Social Security benefits, wrapped in a HelloNation article that lays it all out sans fluff. Forget about hopping on the bandwagon and claiming at the earliest shot—this is a decision as personal as it gets. It's all about...

Continue Reading
Beta Bionics Faces Class Action Over iLet Device Concerns

Updated Category News Views 27

Securities Fraud Allegations Hit Beta Bionics Here's a fresh one on the market front—Beta Bionics is in hot water, and it's not looking pretty. The ticker NASDAQ:BBNX is swirling in the chaos of a class action lawsuit, thanks to a stock tumble that would make even seasoned traders cringe. What's got investors riled up? The nitty-gritty centers on accusations that the...

Continue Reading
AVANT BIO Beef Up Team with Heavyweights Lio, Vanek

Updated Category News Views 175

AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 31

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Vertiv's SmartIT: The New AI Infrastructure Game-Changer

Updated Category News Views 108

Taking AI Infrastructure Up a Notch Vertiv Holdings Co. (NYSE: VRT) is charging ahead with a solution that's bound to rattle the cages of status quo infrastructure deployments. Say hello to Vertiv™ SmartIT, a finely-tuned piece of kit that's pre-engineered to ease up the often painful process of high-density AI deployments across various environments—from homey...

Continue Reading
Huawei's D3 Watch: Revolutionizing Blood Pressure Care

Updated Category News Views 130

Hypertension's New Tech Buddy: The Huawei Watch D3 Here we go again—unveiling stuff that might just change how we look at high blood pressure. Huawei's unfurling their latest gadget at the ISH-ECS 2026 in Dubai, showing off the Huawei Watch D3, which could be a game-changer in health tech. It's about time someone made blood pressure checks less of a chore and more of a...

Continue Reading

Top 5 Most Recently Viewed Articles

3D Systems Secures $7.65 Million for Groundbreaking Printer Tech

Updated Category News Views 109

3D Systems Triumphs with $7.65 Million Contract from U.S. Air Force 3D Systems (NYSE: DDD), a frontrunner in additive manufacturing solutions, has received an impressive contract valued at $7.65 million from the U.S. Air Force. This contract is designated for the development of a Large-format Metal 3D Printer Advanced Technology Demonstrator, referred to as...

Continue Reading
Roaming Hunger Rallies Food Trucks for Swift Disaster Relief

Updated Category News Views 222

Roaming Hunger Takes Action to Provide Relief Roaming Hunger, renowned as the largest network of food trucks in the nation, is on a mission to support communities facing the aftermath of unfortunate disasters. In a recent initiative, they collaborated with both local and national partners to deliver free meals to disaster relief workers and affected residents in the...

Continue Reading
Growth Trends in Mobile Payment Protection Systems Explored

Updated Category News Views 210

Overview of the Mobile Payment Data Protection System Market The Mobile Payment Data Protection System Market has seen remarkable growth recently. In 2024, its size was estimated at USD 6060 million, and by 2031, it is poised to reach USD 9420 million. This growth trajectory marks a compound annual growth rate (CAGR) of 6.6% during this period, showcasing the increasing...

Continue Reading
Illumina Unveils MiSeq i100 Series for Rapid Sequencing

Updated Category News Views 94

Illumina's New MiSeq i100 Series: A Game Changer Illumina, Inc. (NASDAQ: ILMN), a frontrunner in the field of DNA sequencing and array technologies, has introduced an exciting advancement in laboratory sequencing technology—the MiSeq i100 Series. This innovative product line is set to revolutionize how researchers engage in next-generation sequencing (NGS). Enhancing...

Continue Reading
Bet on Canada's Next Leader with $TRUMP Memecoin at Cloudbet

Updated Category News Views 151

Betting on Canada's Political Future with $TRUMP As political landscapes evolve, innovative platforms like Cloudbet are at the forefront, offering unique betting opportunities in the realm of cryptocurrency. Recently, Cloudbet, a well-known crypto sportsbook, introduced the chance to wager on the upcoming Canadian Prime Minister using the $TRUMP memecoin, adding it to a...

Continue Reading